![David O'Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David O'Neill
Directeur/Membre du Conseil chez
Triphase Accelerator Corp.
Profil
David O'Neill currently works at Triphase Accelerator Corp., as Director from 2018.
Dr. O'Neill also formerly worked at Fight Against Cancer Innovation Trust, as President from 2017 to 2025.
Dr. O'Neill received his graduate degree from the University of Western Ontario.
Postes actifs de David O'Neill
| Sociétés | Poste | Début |
|---|---|---|
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de David O'Neill
| Sociétés | Poste | Fin |
|---|---|---|
Fight Against Cancer Innovation Trust
 Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Private Equity Investor | 06/01/2025 |
Formation de David O'Neill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Finance |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Health Technology |
